$33.11 0.26 (+0.79%)
11/25/2009 4:01 PM

Valeant Pharmaceuticals International (VRX)

CAPS Rating: 2 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Featured Broker Partners